Prostate cancer is the second most common cancer in men. In fact, about 1 in 7 men will be diagnosed with this disease during his lifetime. However, most cases are detected in an early stage and are low-risk, posing little or no threat to the patient.
KOELIS, The Prostate Care Company, proposes new concepts and guidelines in prostate care management. Based on MRI-Ultrasound fusion technique, tumors can be effectively treated without affecting patients’ quality of life.
KOELIS Trinity™ and KOELIS software solutions, featured and validated in more than 70 clinical publications, are used nowadays in around 200 sites located in the United States and more than 30 countries all over the world.